ROIV
Roivant Sciences Ltd.
Stock
$35.72+0.22 (+0.62%)Close Oct 2, 2026
- Shareholders' equity, FY2025
- $4.5B
- YoY, FY2025
- −3.4%
- 5-year CAGR
- +20.3%
Shareholders' equity
Shareholders' equity by fiscal year
| Period | Equity | YoY |
|---|---|---|
| FY2025 | $4.5B | −3.4% |
| FY2024 | $4.7B | −21.5% |
| FY2023 | $6.0B | +415.5% |
| FY2022 | $1.2B | −30.1% |
| FY2021 | $1.7B | −7.8% |
| FY2020 | $1.8B | — |